首页 > 最新文献

Proceedings of the Society for Experimental Biology and Medicine最新文献

英文 中文
Low-protein diet changes thyroid function in lactating rats. 低蛋白饮食对哺乳期大鼠甲状腺功能的影响。
Pub Date : 2000-09-01 DOI: 10.1046/j.1525-1373.2000.22429.x
C F Ramos, C V Teixeira, M C Passos, C C Pazos-Moura, P C Lisboa, F H Curty, E G de Moura

Lactating rats were fed with free access to an 8% protein-restricted diet (PR); the control group was fed a 23% protein diet (C). An energy-restricted (pair-fed) group was given the same food as the animals in the control group, but the amounts of food consumed by both PF and PR were about the same. The body weight and serum albumin concentration of PR and PF dams were significantly (P < 0. 05) lower than that of the controls. The PR group had a significant increase in serum-free triiodothyronine (FT3) concentration, 24-hr mammary gland and milk radioiodine (I131) uptake (67%, 278%, and 200%, respectively) as compared with the controls. On the other hand, those animals had a significantly lower serum-free thyroxine (FT4) concentration and 2- and 24-hr thyroid I131 uptake (67%, 64%, and 74%, respectively). Protein malnutrition during lactation did not alter thyroid or liver 5'-deiodinase activity significantly. However, PF dams had a significantly lower (25%) thyroid 5'-deiodinase activity. These data suggest that protein-restricted lactating dams had an adaptive change in the thyroid function, which could be important to increase the transference of iodine or triiodothyronine through the milk to their pups and prevent sequelae of neonatal hypothyroidism.

泌乳大鼠自由饲喂8%蛋白质限制饲料(PR);对照组饲喂23%的蛋白质饲料(C)。能量限制(配对喂养)组给予与对照组动物相同的食物,但PF和PR消耗的食物量大致相同。PR和PF水坝的体重和血清白蛋白浓度显著高于对照组(P < 0.05)。05)低于对照组。与对照组相比,PR组血清游离三碘甲状腺原氨酸(FT3)浓度、24小时乳腺和乳汁放射性碘(I131)摄取(分别为67%、278%和200%)显著增加。另一方面,这些动物的血清游离甲状腺素(FT4)浓度和2小时和24小时甲状腺I131摄取显著降低(分别为67%,64%和74%)。哺乳期蛋白质营养不良对甲状腺和肝脏5′-脱碘酶活性无显著影响。然而,PF坝的甲状腺5′-脱碘酶活性显著降低(25%)。这些数据表明,限制蛋白泌乳公鼠的甲状腺功能发生了适应性变化,这可能对增加碘或三碘甲状腺原氨酸通过乳汁传递给幼崽和预防新生儿甲状腺功能减退的后遗症具有重要意义。
{"title":"Low-protein diet changes thyroid function in lactating rats.","authors":"C F Ramos,&nbsp;C V Teixeira,&nbsp;M C Passos,&nbsp;C C Pazos-Moura,&nbsp;P C Lisboa,&nbsp;F H Curty,&nbsp;E G de Moura","doi":"10.1046/j.1525-1373.2000.22429.x","DOIUrl":"https://doi.org/10.1046/j.1525-1373.2000.22429.x","url":null,"abstract":"<p><p>Lactating rats were fed with free access to an 8% protein-restricted diet (PR); the control group was fed a 23% protein diet (C). An energy-restricted (pair-fed) group was given the same food as the animals in the control group, but the amounts of food consumed by both PF and PR were about the same. The body weight and serum albumin concentration of PR and PF dams were significantly (P < 0. 05) lower than that of the controls. The PR group had a significant increase in serum-free triiodothyronine (FT3) concentration, 24-hr mammary gland and milk radioiodine (I131) uptake (67%, 278%, and 200%, respectively) as compared with the controls. On the other hand, those animals had a significantly lower serum-free thyroxine (FT4) concentration and 2- and 24-hr thyroid I131 uptake (67%, 64%, and 74%, respectively). Protein malnutrition during lactation did not alter thyroid or liver 5'-deiodinase activity significantly. However, PF dams had a significantly lower (25%) thyroid 5'-deiodinase activity. These data suggest that protein-restricted lactating dams had an adaptive change in the thyroid function, which could be important to increase the transference of iodine or triiodothyronine through the milk to their pups and prevent sequelae of neonatal hypothyroidism.</p>","PeriodicalId":20675,"journal":{"name":"Proceedings of the Society for Experimental Biology and Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2000-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21799562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 48
Detection of antigen-specific human serum proteins related to the T-cell receptor in infectious disease and in an immune response to milk proteins or chemicals. 在传染病和对牛奶蛋白或化学物质的免疫反应中与t细胞受体相关的抗原特异性人血清蛋白的检测。
Pub Date : 2000-09-01 DOI: 10.1046/j.1525-1373.2000.22430.x
C H Little, G M Georgiou, G Fey, B Ravindran, J Levine, H Ogedegbe, H Yamase, R E Cone

A monoclonal IgG2 antibody, MG3C9-1 A12, was prepared by immunization of mice with human serum Cohn Fraction III proteins enriched for TCR Ca+ proteins. MG3C9-1 A12 bound to Mr 28,000, antigen-specific TCR Ca+, beta-, and TCR Ca+, beta+ serum proteins associated with TGF-beta1, 2. The IgG2 monoclonal antibody also bound to T-lymphocyte proteins but did not bind to B lymphocyte proteins, human albumin, IgM, IgG, IgA, or TGF-beta1, 2, 3 immunogenic peptides. Monoclonal MG3C9-1 A12 detected TCR-related proteins specific for filarial extract, milk proteins, or benzoic acid in the sera of individuals with chronic or asymptomatic filariasis, milk intolerance, or sensitivity to toluene, respectively. TCR-related serum proteins were also detected intracellularly in mononuclear cells in frozen sections of ileum from a patient with milk intolerance and reactive mesenteric lymph nodes from a patient with a gastric ulcer. The results suggest that antigen-specific TCR-related serum proteins may be elevated during an immune response to oral, environmental, or infectious stimuli.

用富含TCR Ca+蛋白的人血清Cohn Fraction III蛋白免疫小鼠制备IgG2单克隆抗体MG3C9-1 A12。mg3c9 - 1a12结合Mr 28000,抗原特异性TCR Ca+, β -和TCR Ca+, β +血清蛋白与tgf - β a1, 2。IgG2单克隆抗体也与t淋巴细胞蛋白结合,但不与B淋巴细胞蛋白、人白蛋白、IgM、IgG、IgA或tgf - β 1,2,3免疫原性肽结合。单克隆MG3C9-1 A12分别检测慢性或无症状丝虫病、牛奶不耐受或甲苯敏感患者血清中丝虫病提取物、牛奶蛋白或苯甲酸特异性tcr相关蛋白。在一名牛奶不耐受患者的回肠冷冻切片和一名胃溃疡患者的反应性肠系膜淋巴结中,也检测到细胞内单个核细胞中的tcr相关血清蛋白。结果表明抗原特异性tcr相关血清蛋白可能在口腔、环境或感染刺激的免疫反应中升高。
{"title":"Detection of antigen-specific human serum proteins related to the T-cell receptor in infectious disease and in an immune response to milk proteins or chemicals.","authors":"C H Little,&nbsp;G M Georgiou,&nbsp;G Fey,&nbsp;B Ravindran,&nbsp;J Levine,&nbsp;H Ogedegbe,&nbsp;H Yamase,&nbsp;R E Cone","doi":"10.1046/j.1525-1373.2000.22430.x","DOIUrl":"https://doi.org/10.1046/j.1525-1373.2000.22430.x","url":null,"abstract":"<p><p>A monoclonal IgG2 antibody, MG3C9-1 A12, was prepared by immunization of mice with human serum Cohn Fraction III proteins enriched for TCR Ca+ proteins. MG3C9-1 A12 bound to Mr 28,000, antigen-specific TCR Ca+, beta-, and TCR Ca+, beta+ serum proteins associated with TGF-beta1, 2. The IgG2 monoclonal antibody also bound to T-lymphocyte proteins but did not bind to B lymphocyte proteins, human albumin, IgM, IgG, IgA, or TGF-beta1, 2, 3 immunogenic peptides. Monoclonal MG3C9-1 A12 detected TCR-related proteins specific for filarial extract, milk proteins, or benzoic acid in the sera of individuals with chronic or asymptomatic filariasis, milk intolerance, or sensitivity to toluene, respectively. TCR-related serum proteins were also detected intracellularly in mononuclear cells in frozen sections of ileum from a patient with milk intolerance and reactive mesenteric lymph nodes from a patient with a gastric ulcer. The results suggest that antigen-specific TCR-related serum proteins may be elevated during an immune response to oral, environmental, or infectious stimuli.</p>","PeriodicalId":20675,"journal":{"name":"Proceedings of the Society for Experimental Biology and Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2000-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21799563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Introduction: Forum on Responsible Conduct in Biomedical Research. 生物医学研究中负责任行为论坛。
Pub Date : 2000-09-01 DOI: 10.1046/j.1525-1373.2000.22421.x
M M Cassidy
{"title":"Introduction: Forum on Responsible Conduct in Biomedical Research.","authors":"M M Cassidy","doi":"10.1046/j.1525-1373.2000.22421.x","DOIUrl":"https://doi.org/10.1046/j.1525-1373.2000.22421.x","url":null,"abstract":"","PeriodicalId":20675,"journal":{"name":"Proceedings of the Society for Experimental Biology and Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2000-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21800205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Ethics in research. 研究中的伦理。
Pub Date : 2000-09-01 DOI: 10.1046/j.1525-1373.2000.22422.x
A E Shamoo, C D Dunigan
{"title":"Ethics in research.","authors":"A E Shamoo,&nbsp;C D Dunigan","doi":"10.1046/j.1525-1373.2000.22422.x","DOIUrl":"https://doi.org/10.1046/j.1525-1373.2000.22422.x","url":null,"abstract":"","PeriodicalId":20675,"journal":{"name":"Proceedings of the Society for Experimental Biology and Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2000-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21800206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Scientific misconduct and research integrity for the bench scientist. 板凳科学家的科学不端行为和研究诚信。
Pub Date : 2000-09-01 DOI: 10.1046/j.1525-1373.2000.22425.x
C B Pascal

This paper describes the role of the Office of Research Integrity (ORI), a component of the Public Health Service (PHS), in defining scientific misconduct in research supported with PHS funds and in establishing standards for responding to allegations of misconduct. The principal methods by which ORI exercises its responsibilities in this area are defining what types of behaviors undertaken by research investigators constitute misconduct, overseeing institutional efforts to investigate and report misconduct, and recommending to the Assistant Secretary for Health (ASH) PHS administrative actions when misconduct is identified. ORI also takes affirmative steps to promote research integrity through education, training, and other initiatives. The role of the research institution in responding to misconduct and promoting research integrity is complementary and overlapping with ORI's efforts but, as the employer of research investigators and front-line manager of the research, the institution has a greater opportunity to promote the highest standards of integrity in the day-to-day conduct of research. Finally, legal precedent established through civil litigation has played an important role in defining the standards that apply in determining when a breach of research integrity has occurred.

本文描述了研究诚信办公室(ORI)的作用,该办公室是公共卫生服务(PHS)的一个组成部分,在定义公共卫生服务资金支持的研究中的科学不端行为以及建立应对不端行为指控的标准方面。ORI在这一领域履行职责的主要方法是确定研究人员所采取的哪些类型的行为构成不当行为,监督机构调查和报告不当行为的努力,并在发现不当行为时向卫生部副部长建议公共卫生服务部门的行政行动。ORI还采取积极措施,通过教育、培训和其他举措促进研究诚信。研究机构在应对不当行为和促进研究诚信方面的作用与ORI的工作是互补和重叠的,但作为研究人员的雇主和研究的一线管理人员,研究机构有更大的机会在日常研究行为中促进最高标准的诚信。最后,通过民事诉讼确立的法律先例在确定何时发生违反研究诚信行为的标准方面发挥了重要作用。
{"title":"Scientific misconduct and research integrity for the bench scientist.","authors":"C B Pascal","doi":"10.1046/j.1525-1373.2000.22425.x","DOIUrl":"https://doi.org/10.1046/j.1525-1373.2000.22425.x","url":null,"abstract":"<p><p>This paper describes the role of the Office of Research Integrity (ORI), a component of the Public Health Service (PHS), in defining scientific misconduct in research supported with PHS funds and in establishing standards for responding to allegations of misconduct. The principal methods by which ORI exercises its responsibilities in this area are defining what types of behaviors undertaken by research investigators constitute misconduct, overseeing institutional efforts to investigate and report misconduct, and recommending to the Assistant Secretary for Health (ASH) PHS administrative actions when misconduct is identified. ORI also takes affirmative steps to promote research integrity through education, training, and other initiatives. The role of the research institution in responding to misconduct and promoting research integrity is complementary and overlapping with ORI's efforts but, as the employer of research investigators and front-line manager of the research, the institution has a greater opportunity to promote the highest standards of integrity in the day-to-day conduct of research. Finally, legal precedent established through civil litigation has played an important role in defining the standards that apply in determining when a breach of research integrity has occurred.</p>","PeriodicalId":20675,"journal":{"name":"Proceedings of the Society for Experimental Biology and Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2000-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21798946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feeding DHEA to C57/B167 mice: the authors respond 给C57/B167小鼠喂食脱氢表雄酮:作者的反应
Pub Date : 2000-09-01 DOI: 10.1046/j.1525-1373.2000.22437.x
Bennett, Catalina, Kumar, Milewich
{"title":"Feeding DHEA to C57/B167 mice: the authors respond","authors":"Bennett,&nbsp;Catalina,&nbsp;Kumar,&nbsp;Milewich","doi":"10.1046/j.1525-1373.2000.22437.x","DOIUrl":"https://doi.org/10.1046/j.1525-1373.2000.22437.x","url":null,"abstract":"","PeriodicalId":20675,"journal":{"name":"Proceedings of the Society for Experimental Biology and Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2000-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21800204","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inhibition of ethanol-induced liver disease in the intragastric feeding rat model by chlormethiazole. 氯甲唑对灌胃大鼠酒精性肝病的抑制作用。
Pub Date : 2000-09-01 DOI: 10.1046/j.1525-1373.2000.22435.x
Z Gouillon, D Lucas, J Li, A L Hagbjork, B A French, P Fu, C Fang, M Ingelman-Sundberg, T M Donohue, S W French

The purpose of this investigation was to assess the effect of chlormethiazole treatment on liver damage in the experimental rat intragastric ethanol-feeding model of alcoholic liver disease. Chlormethiazole has been used in the treatment of alcoholic withdrawal and has been shown to inhibit cytochrome P4502E1. Since treatment of experimental alcoholic liver disease with CYP2E1 inhibitors had an ameliorating effect on liver injury in the rat, chlormethiazole was used to see if it had a similar effect. Rats fed ethanol for 2 months had significantly less liver injury when chlormethiazole was added to the diet, fed intragastrically. The CYP2E1 apoprotein levels, which were increased by ethanol feeding, were also increased when chlormethiazole was fed with ethanol. Chlormethiazole inhibited the increase in the ethanol-induced CYP2E1 activity in vivo, as measured by chlorzoxazone 6-hydroxylation, but did not affect the level of CYP2E1 apoprotein. Likewise, the reduction in proteasome proteolytic enzyme activity produced by ethanol feeding was blunted in chlormethiazole-fed rats. These results support the conclusion that chlormethiazole treatment partially protects the liver from injury by inhibiting CYP2E1 activity in vivo.

本研究旨在探讨氯甲唑对酒精性肝病大鼠灌胃乙醇喂养模型肝损伤的影响。氯甲基唑已被用于治疗酒精戒断,并已被证明可抑制细胞色素P4502E1。由于用CYP2E1抑制剂治疗实验性酒精性肝病对大鼠肝损伤有改善作用,所以我们使用氯甲基唑来观察它是否有类似的效果。饲喂乙醇2个月的大鼠,在饲料中添加氯甲基唑并灌胃,肝损伤明显减轻。与乙醇饲喂相比,氯甲唑的CYP2E1载脂蛋白水平也有所升高。氯代唑酮6-羟基化法测定,氯甲基唑抑制了体内乙醇诱导的CYP2E1活性的增加,但不影响CYP2E1载子蛋白的水平。同样,在氯甲唑喂养的大鼠中,乙醇喂养产生的蛋白酶体蛋白水解酶活性的降低被钝化。这些结果支持了氯甲唑治疗通过抑制体内CYP2E1活性部分保护肝脏损伤的结论。
{"title":"Inhibition of ethanol-induced liver disease in the intragastric feeding rat model by chlormethiazole.","authors":"Z Gouillon,&nbsp;D Lucas,&nbsp;J Li,&nbsp;A L Hagbjork,&nbsp;B A French,&nbsp;P Fu,&nbsp;C Fang,&nbsp;M Ingelman-Sundberg,&nbsp;T M Donohue,&nbsp;S W French","doi":"10.1046/j.1525-1373.2000.22435.x","DOIUrl":"https://doi.org/10.1046/j.1525-1373.2000.22435.x","url":null,"abstract":"<p><p>The purpose of this investigation was to assess the effect of chlormethiazole treatment on liver damage in the experimental rat intragastric ethanol-feeding model of alcoholic liver disease. Chlormethiazole has been used in the treatment of alcoholic withdrawal and has been shown to inhibit cytochrome P4502E1. Since treatment of experimental alcoholic liver disease with CYP2E1 inhibitors had an ameliorating effect on liver injury in the rat, chlormethiazole was used to see if it had a similar effect. Rats fed ethanol for 2 months had significantly less liver injury when chlormethiazole was added to the diet, fed intragastrically. The CYP2E1 apoprotein levels, which were increased by ethanol feeding, were also increased when chlormethiazole was fed with ethanol. Chlormethiazole inhibited the increase in the ethanol-induced CYP2E1 activity in vivo, as measured by chlorzoxazone 6-hydroxylation, but did not affect the level of CYP2E1 apoprotein. Likewise, the reduction in proteasome proteolytic enzyme activity produced by ethanol feeding was blunted in chlormethiazole-fed rats. These results support the conclusion that chlormethiazole treatment partially protects the liver from injury by inhibiting CYP2E1 activity in vivo.</p>","PeriodicalId":20675,"journal":{"name":"Proceedings of the Society for Experimental Biology and Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2000-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21800660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antisperm antibodies associated with infertility: properties and encoding genes of target antigens. 与不孕症相关的抗精子抗体:目标抗原的特性和编码基因。
Pub Date : 2000-07-01 DOI: 10.1046/j.1525-1373.2000.22410.x
S S Koide, L Wang, M Kamada

Infertility among couples of reproductive age is a perplexing condition when the cause is indeterminate. These cases are classified as unexplained infertility. In a subset of subjects, antisperm antibodies with sperm agglutinating and/or immobilizing activities have been detected in the blood or fluids of the reproductive tract. These cases are designated as immunologic infertility although a cause and effect relationship of the antibodies to infertility has not been established. In this review, seven target sperm antigens to antibodies associated with infertility and their encoding genes are described. The antisperm antibodies (ASAs) examined were obtained from infertile women or were monoclonal antibodies (mAb) raised against human sperm proteins. All the ASAs studied possessed potent sperm agglutinating and/or immobilizing activities. The target antigens were isolated from human and other mammalian sperm, and the encoding genes identified. The seven antigens are YWK-II, BE-20, rSMP-B, BS-63 (nucleoporin-related), BS-17 (calpastatin), HED-2 (zyxin), and 75- kDa. Each antigen is a distinct and separate entity and is produced by different cells of the reproductive tract, (e.g., germ cells, epididymal epithelial cells, and Sertoli cells). No single predominant target component has been found to interact with the ASAs. It is proposed that immunologic infertility is the consequence of the combined actions of multiple ASAs in immobilizing and/or agglutinating spermatozoa, blocking spermegg interaction, preventing implantation, and/or arresting embryo development.

育龄夫妇的不孕症是一个令人困惑的情况,因为原因不明。这些病例被归类为不明原因的不孕症。在一部分受试者中,在生殖道的血液或液体中检测到具有精子凝集和/或固定活性的抗精子抗体。这些病例被指定为免疫性不孕症,尽管不孕抗体的因果关系尚未确定。本文综述了7种与不孕症相关的精子靶抗原及其编码基因。检测的抗精子抗体(asa)是从不育妇女中获得的,或者是针对人类精子蛋白产生的单克隆抗体(mAb)。所研究的所有asa都具有强大的精子凝集和/或固定活性。从人类和其他哺乳动物精子中分离出目标抗原,并鉴定出编码基因。这7种抗原分别是YWK-II、BE-20、rSMP-B、BS-63(核孔蛋白相关)、BS-17 (calpastatin)、HED-2 (zyxin)和75- kDa。每种抗原都是一种独特的、独立的实体,由生殖道的不同细胞(如生殖细胞、附睾上皮细胞和支持细胞)产生。没有发现单一的主要目标成分与asa相互作用。免疫不育是多种asa在固定和/或凝集精子、阻断精子相互作用、阻止着床和/或阻止胚胎发育等方面共同作用的结果。
{"title":"Antisperm antibodies associated with infertility: properties and encoding genes of target antigens.","authors":"S S Koide,&nbsp;L Wang,&nbsp;M Kamada","doi":"10.1046/j.1525-1373.2000.22410.x","DOIUrl":"https://doi.org/10.1046/j.1525-1373.2000.22410.x","url":null,"abstract":"<p><p>Infertility among couples of reproductive age is a perplexing condition when the cause is indeterminate. These cases are classified as unexplained infertility. In a subset of subjects, antisperm antibodies with sperm agglutinating and/or immobilizing activities have been detected in the blood or fluids of the reproductive tract. These cases are designated as immunologic infertility although a cause and effect relationship of the antibodies to infertility has not been established. In this review, seven target sperm antigens to antibodies associated with infertility and their encoding genes are described. The antisperm antibodies (ASAs) examined were obtained from infertile women or were monoclonal antibodies (mAb) raised against human sperm proteins. All the ASAs studied possessed potent sperm agglutinating and/or immobilizing activities. The target antigens were isolated from human and other mammalian sperm, and the encoding genes identified. The seven antigens are YWK-II, BE-20, rSMP-B, BS-63 (nucleoporin-related), BS-17 (calpastatin), HED-2 (zyxin), and 75- kDa. Each antigen is a distinct and separate entity and is produced by different cells of the reproductive tract, (e.g., germ cells, epididymal epithelial cells, and Sertoli cells). No single predominant target component has been found to interact with the ASAs. It is proposed that immunologic infertility is the consequence of the combined actions of multiple ASAs in immobilizing and/or agglutinating spermatozoa, blocking spermegg interaction, preventing implantation, and/or arresting embryo development.</p>","PeriodicalId":20675,"journal":{"name":"Proceedings of the Society for Experimental Biology and Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2000-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21708030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The possible role of prolactin in the circadian rhythm of leptin secretion in male rats. 催乳素在雄性大鼠瘦素分泌昼夜节律中的可能作用。
Pub Date : 2000-07-01 DOI: 10.1046/j.1525-1373.2000.22414.x
C A Mastronardi, A Walczewska, W H Yu, S Karanth, A F Parlow, S M McCann

In humans there is a circadian rhythm of leptin concentrations in plasma with a minimum in the early morning and a maximum in the middle of the night. By taking blood samples from adult male rats every 3 hr for 24 hr, we determined that a circadian rhythm of plasma leptin concentrations also occurs in the rat with a peak at 0130h and a minimum at 0730h. To determine if this rhythm is controlled by nocturnally released hormones, we evaluated the effect of hormones known to be released at night in humans, some of which are also known to be released at night in rats. In humans, prolactin (PRL), growth hormone (GH), and melatonin are known to be released at night, and adrenocorticotropic hormone (ACTH) release is inhibited. In these experiments, conscious rats were injected intravenously with 0.5 ml diluent or the substance to be evaluated just after removal of the first blood sample (0.3 ml), and additional blood samples (0.3 ml) were drawn every 10 min thereafter for 2 hr. The injection of highly purified sheep PRL (500 microg) produced a rapid increase in plasma leptin that persisted for the duration of the experiment. Lower doses were ineffective. To determine the effect of blockade of PRL secretion on leptin secretion, alpha bromoergocryptine (1.5 mg), a dopamine-2-receptor agonist that rapidly inhibits PRL release, was injected. It produced a rapid decline in plasma leptin within 10 min, and the decline persisted for 120 min. The minimal effective dose of GH to lower plasma leptin was 1 mg/rat. Insulin-like growth factor (IGF-1) (10 microg), but not IGF-2 (10 microg), also significantly decreased plasma leptin. Melatonin, known to be nocturnally released in humans and rats, was injected at a dose of 1 mg/rat during daytime (1100h) or nighttime (2300h). It did not alter leptin release significantly. Dexamethasone (DEX), a potent glucocorticoid, was ineffective at a 0. 1-mg dose but produced a delayed, significant increase in leptin, manifest 100-120 min after injection of a 1 mg dose. Since glucocorticoids decrease at night in humans at the time of the maximum plasma concentrations of leptin, we hypothesize that this increase in leptin from a relatively high dose of DEX would mimic the response to the release of corticosterone following stress in the rat and that glucocorticoids are not responsible for the circadian rhythm of leptin concentration. Therefore, we conclude that an increase in PRL secretion during the night may be responsible, at least in part, for the nocturnal elevation of leptin concentrations observed in rats and humans.

人体血浆中瘦素浓度有昼夜节律,清晨最低,午夜最高。通过在24小时内每3小时采集一次成年雄性大鼠的血液样本,我们确定大鼠的血浆瘦素浓度也存在昼夜节律,在0130h达到峰值,在0730h达到最低。为了确定这种节律是否受夜间释放的激素控制,我们评估了人类在夜间释放的激素的影响,其中一些激素在夜间也会在老鼠身上释放。在人类中,泌乳素(PRL)、生长激素(GH)和褪黑激素在夜间被释放,促肾上腺皮质激素(ACTH)的释放被抑制。在这些实验中,清醒的大鼠在取出第一个血样(0.3 ml)后立即静脉注射0.5 ml稀释剂或待评估物质,此后每10分钟再抽取0.3 ml血样,持续2小时。高纯度绵羊PRL(500微克)的注射使血浆瘦素迅速增加,并在实验期间持续增加。较低剂量无效。为了确定阻断PRL分泌对瘦素分泌的影响,注射可快速抑制PRL释放的多巴胺-2受体激动剂α -溴代隐碱(1.5 mg)。在10分钟内使血浆瘦素迅速下降,并持续下降120分钟。生长激素降低血浆瘦素的最小有效剂量为1 mg/大鼠。胰岛素样生长因子(IGF-1)(10微克),而不是IGF-2(10微克),也显著降低血浆瘦素。褪黑素是人类和大鼠在夜间释放的,在白天(1100小时)或夜间(2300小时)注射剂量为1mg /大鼠。它没有显著改变瘦素的释放。地塞米松(Dexamethasone, DEX)是一种强效糖皮质激素,在0时无效。1毫克剂量,但产生延迟,显著增加瘦素,表现在注射1毫克剂量后100-120分钟。由于人体内的糖皮质激素在夜间会减少,而此时正是血中瘦素浓度最高的时候,因此我们假设,相对高剂量的DEX导致的瘦素增加可能与大鼠应激后皮质酮释放的反应类似,而糖皮质激素并不是导致瘦素浓度昼夜节律的原因。因此,我们得出结论,夜间PRL分泌的增加可能是夜间瘦素浓度升高的原因,至少部分原因是在大鼠和人类中观察到的。
{"title":"The possible role of prolactin in the circadian rhythm of leptin secretion in male rats.","authors":"C A Mastronardi,&nbsp;A Walczewska,&nbsp;W H Yu,&nbsp;S Karanth,&nbsp;A F Parlow,&nbsp;S M McCann","doi":"10.1046/j.1525-1373.2000.22414.x","DOIUrl":"https://doi.org/10.1046/j.1525-1373.2000.22414.x","url":null,"abstract":"<p><p>In humans there is a circadian rhythm of leptin concentrations in plasma with a minimum in the early morning and a maximum in the middle of the night. By taking blood samples from adult male rats every 3 hr for 24 hr, we determined that a circadian rhythm of plasma leptin concentrations also occurs in the rat with a peak at 0130h and a minimum at 0730h. To determine if this rhythm is controlled by nocturnally released hormones, we evaluated the effect of hormones known to be released at night in humans, some of which are also known to be released at night in rats. In humans, prolactin (PRL), growth hormone (GH), and melatonin are known to be released at night, and adrenocorticotropic hormone (ACTH) release is inhibited. In these experiments, conscious rats were injected intravenously with 0.5 ml diluent or the substance to be evaluated just after removal of the first blood sample (0.3 ml), and additional blood samples (0.3 ml) were drawn every 10 min thereafter for 2 hr. The injection of highly purified sheep PRL (500 microg) produced a rapid increase in plasma leptin that persisted for the duration of the experiment. Lower doses were ineffective. To determine the effect of blockade of PRL secretion on leptin secretion, alpha bromoergocryptine (1.5 mg), a dopamine-2-receptor agonist that rapidly inhibits PRL release, was injected. It produced a rapid decline in plasma leptin within 10 min, and the decline persisted for 120 min. The minimal effective dose of GH to lower plasma leptin was 1 mg/rat. Insulin-like growth factor (IGF-1) (10 microg), but not IGF-2 (10 microg), also significantly decreased plasma leptin. Melatonin, known to be nocturnally released in humans and rats, was injected at a dose of 1 mg/rat during daytime (1100h) or nighttime (2300h). It did not alter leptin release significantly. Dexamethasone (DEX), a potent glucocorticoid, was ineffective at a 0. 1-mg dose but produced a delayed, significant increase in leptin, manifest 100-120 min after injection of a 1 mg dose. Since glucocorticoids decrease at night in humans at the time of the maximum plasma concentrations of leptin, we hypothesize that this increase in leptin from a relatively high dose of DEX would mimic the response to the release of corticosterone following stress in the rat and that glucocorticoids are not responsible for the circadian rhythm of leptin concentration. Therefore, we conclude that an increase in PRL secretion during the night may be responsible, at least in part, for the nocturnal elevation of leptin concentrations observed in rats and humans.</p>","PeriodicalId":20675,"journal":{"name":"Proceedings of the Society for Experimental Biology and Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2000-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21708688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 36
Skeletal muscle as a myocardial substitute. 骨骼肌作为心肌的替代品。
Pub Date : 2000-07-01 DOI: 10.1046/j.1525-1373.2000.22411.x
L I Astra, L W Stephenson

Skeletal muscle has long been used in the field of cardiac surgery. Its use has progressed from providing myocardial reinforcement to assisting the heart by actively pumping blood. Early experiments revealed that skeletal muscle assistance could augment pressures and blood flow; however, the results were short-lived due to muscle fatigue. It was later shown that skeletal muscle can be conditioned electrically to be fatigue resistant and therefore may be useful for performing cardiac-type work. Once the details were formed of how to stimulate and manipulate the muscle to assist the heart, several configurations were devised. Cardiomyoplasty and aortomyoplasty refer to wrapping skeletal muscle around the heart or aorta, respectively. These techniques have been applied in humans; however, the effectiveness is controversial. Although most patients improve clinically, the hemodynamic parameters have not shown consistent improvements, and survival data are unknown. Skeletal muscle ventricles offer a promising alternative to both cardiomyoplasty and aortomyoplasty. These are completely separate pumping chambers constructed from skeletal muscle and connected to the circulation in a variety of configurations. Although these have not been tried in humans, the animal data appear quite convincing. The skeletal muscle ventricles have shown the greatest improvements on hemodynamic parameters with great stability over time.

骨骼肌长期以来被用于心脏外科领域。它的用途已经从提供心肌强化发展到通过主动泵血来辅助心脏。早期实验显示,骨骼肌辅助可以增加压力和血流量;然而,由于肌肉疲劳,结果是短暂的。后来的研究表明,骨骼肌可以通过电调节来抵抗疲劳,因此可能对执行心脏类型的工作有用。一旦形成了如何刺激和操纵肌肉来辅助心脏的细节,就会设计出几种结构。心肌成形术和主动脉成形术分别是指将骨骼肌包裹在心脏或主动脉周围。这些技术已经应用于人类;然而,其有效性是有争议的。虽然大多数患者在临床上有所改善,但血流动力学参数并未显示出一致的改善,生存数据未知。骨骼肌心室提供了一个有希望的替代心肌成形术和主动脉成形术。这些是由骨骼肌构成的完全独立的泵室,并以各种配置连接到循环系统。虽然这些还没有在人类身上试验过,但动物数据似乎很有说服力。随着时间的推移,骨骼肌心室在血流动力学参数方面表现出最大的改善,并具有很大的稳定性。
{"title":"Skeletal muscle as a myocardial substitute.","authors":"L I Astra,&nbsp;L W Stephenson","doi":"10.1046/j.1525-1373.2000.22411.x","DOIUrl":"https://doi.org/10.1046/j.1525-1373.2000.22411.x","url":null,"abstract":"<p><p>Skeletal muscle has long been used in the field of cardiac surgery. Its use has progressed from providing myocardial reinforcement to assisting the heart by actively pumping blood. Early experiments revealed that skeletal muscle assistance could augment pressures and blood flow; however, the results were short-lived due to muscle fatigue. It was later shown that skeletal muscle can be conditioned electrically to be fatigue resistant and therefore may be useful for performing cardiac-type work. Once the details were formed of how to stimulate and manipulate the muscle to assist the heart, several configurations were devised. Cardiomyoplasty and aortomyoplasty refer to wrapping skeletal muscle around the heart or aorta, respectively. These techniques have been applied in humans; however, the effectiveness is controversial. Although most patients improve clinically, the hemodynamic parameters have not shown consistent improvements, and survival data are unknown. Skeletal muscle ventricles offer a promising alternative to both cardiomyoplasty and aortomyoplasty. These are completely separate pumping chambers constructed from skeletal muscle and connected to the circulation in a variety of configurations. Although these have not been tried in humans, the animal data appear quite convincing. The skeletal muscle ventricles have shown the greatest improvements on hemodynamic parameters with great stability over time.</p>","PeriodicalId":20675,"journal":{"name":"Proceedings of the Society for Experimental Biology and Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2000-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21708031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Proceedings of the Society for Experimental Biology and Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1